Difference between revisions of "Amyloid"

Jump to navigation Jump to search
5 bytes added ,  01:44, 18 June 2010
m
Line 57: Line 57:
#AL amyloidosis - "AL" = ''Amyloid Light chain''.<ref name=pmid9573002>{{Cite journal  | last1 = Comenzo | first1 = RL. | last2 = Vosburgh | first2 = E. | last3 = Falk | first3 = RH. | last4 = Sanchorawala | first4 = V. | last5 = Reisinger | first5 = J. | last6 = Dubrey | first6 = S. | last7 = Dember | first7 = LM. | last8 = Berk | first8 = JL. | last9 = Akpek | first9 = G. | title = Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. | journal = Blood | volume = 91 | issue = 10 | pages = 3662-70 | month = May | year = 1998 | doi =  | PMID = 9573002 }}</ref>
#AL amyloidosis - "AL" = ''Amyloid Light chain''.<ref name=pmid9573002>{{Cite journal  | last1 = Comenzo | first1 = RL. | last2 = Vosburgh | first2 = E. | last3 = Falk | first3 = RH. | last4 = Sanchorawala | first4 = V. | last5 = Reisinger | first5 = J. | last6 = Dubrey | first6 = S. | last7 = Dember | first7 = LM. | last8 = Berk | first8 = JL. | last9 = Akpek | first9 = G. | title = Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. | journal = Blood | volume = 91 | issue = 10 | pages = 3662-70 | month = May | year = 1998 | doi =  | PMID = 9573002 }}</ref>
#*Primary amyloidosis.<ref name=merck>Amyloidosis. Merck Manual. URL: [http://www.merck.com/mmpe/sec12/ch160/ch160a.html http://www.merck.com/mmpe/sec12/ch160/ch160a.html]. Accessed on: 3 December 2009.</ref>
#*Primary amyloidosis.<ref name=merck>Amyloidosis. Merck Manual. URL: [http://www.merck.com/mmpe/sec12/ch160/ch160a.html http://www.merck.com/mmpe/sec12/ch160/ch160a.html]. Accessed on: 3 December 2009.</ref>
#*Bence Jones protein (light chains -- kappa or lambda) +ve -- necessary for amyloidosis but not sufficient.<ref>PBoD P.261.</ref>
#*Bence Jones protein (light chains -- kappa or lambda) +ve -- necessary for amyloidosis but not sufficient.<ref>{{Ref_PBoD|261}}</ref>
#AA amyloidosis - "AA" = ''Amyloid Associated''.<ref>{{Ref_PBoD|259}}</ref>
#AA amyloidosis - "AA" = ''Amyloid Associated''.<ref>{{Ref_PBoD|259}}</ref>
#*Secondary amyloidosis.
#*Secondary amyloidosis.
48,466

edits

Navigation menu